NEIMETH — NEIMETH INTERNATIONAL PHARMACEUTICALS Disclosures
2 filings on the Nigerian Exchange Group.
NEIMETH INTERNATIONAL PHARMACEUTICALS (NEIMETH) is listed on the Nigerian Exchange Group (NGX). This page tracks every regulatory disclosure NEIMETH INTERNATIONAL PHARMACEUTICALS has filed with the exchange — covering director dealings and financial results — with plain-English summaries and direct links to each official PDF. The most recent filing was on 8 Aug 2026, and the records here go back to 29 Jul 2026. NEIMETH INTERNATIONAL PHARMACEUTICALS has a market capitalisation of about ₦39.31B and currently carries a HOLD signal on Aboki Forex's fundamental model.
NEIMETH Stock Snapshot
HOLD · 51.5/100Market Cap
₦39.31B
P/E Ratio
39.90
EPS (₦)
0.23
ROE %
35.84
Div Yield %
—
P/B Ratio
14.30
Latest NEIMETH filings
Director Dealing 8 Aug 2026
NEIMETH INTERNATIONAL PHARMACEUTICALS PLC DIRECTORSDEALINGS
* Clinoscope Services Limited, a substantial shareholder, acquired 40,000,000 ordinary shares of Neimeth International Pharmaceuticals Plc.
* The transaction took place on August 04, 2026, at a price of ₦7.80 per share.
📄 View PDF
Financial Results 29 Jul 2026
NEIMETH INTERNATIONAL PHARMACEUTICALS PLC- QUARTER 2 - FINANCIAL STATEMENT FOR 2026
📄 View PDF
What these NEIMETH disclosures mean
Director Dealing
Disclosure of purchases or sales of NEIMETH shares by the company's directors and other insiders, as required by Nigerian Exchange rules.
Financial Results
Audited or unaudited financial statements showing NEIMETH INTERNATIONAL PHARMACEUTICALS's revenue, profit, and balance-sheet position for a reporting period. These are the primary source for tracking the company's performance.
NEIMETH disclosures — frequently asked questions
NEIMETH INTERNATIONAL PHARMACEUTICALS has 2 recent disclosures on record on the Nigerian Exchange Group, covering director dealings and financial results. The most recent was filed on 8 Aug 2026. Each filing on this page links to the official PDF on the NGX document library.
Every NEIMETH disclosure on this page links directly to the official PDF published on the Nigerian Exchange (NGX) document library. You can also get push notifications the moment NEIMETH INTERNATIONAL PHARMACEUTICALS files a new disclosure by using the Aboki Forex app.
Based on Aboki Forex's fundamental model, NEIMETH currently carries a HOLD signal with a fundamental score of 51.5/100, a P/E ratio of 39.90 and a return on equity of 35.84%. This is not investment advice — review the full fundamentals and the latest disclosures before deciding.
NEIMETH INTERNATIONAL PHARMACEUTICALS (NEIMETH) has a market capitalisation of approximately ₦39.31B on the Nigerian Exchange Group.
NGX-listed companies like NEIMETH INTERNATIONAL PHARMACEUTICALS file disclosures whenever there is a material event — typically quarterly and annual financial results, plus board meetings, AGM notices, dividend declarations and director dealings as they happen. This page is rebuilt regularly so the latest NEIMETH filings always appear at the top.